First approval in 16 years for mesothelioma, a type of cancer caused by inhaling asbestos fibers
SILVER SPRING, Md., Oct. 2, 2020 /PRNewswire/ -- Today, the U.S. Food...
Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.
HARVARD RESEARCHERS MAY HAVE discovered the cause of multiple sclerosis (MS). This progressive disease affects 2.8 million individuals worldwide, and there is no cure.
In the...